As of April 16, 2025, Kymera Therapeutics (KYMR) has a market cap of $1.65 billion USD. According to our data, Kymera Therapeutics is ranked No.4275 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.65 B |
-36.54%
|
Dec 31, 2024 | $2.61 B |
58.01%
|
Dec 29, 2023 | $1.65 B |
2.00%
|
Dec 30, 2022 | $1.62 B |
-60.69%
|
Dec 31, 2021 | $4.11 B |
2.40%
|
Dec 31, 2020 | $4.02 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Arvinas
ARVN
|
$0.52 B |
0.000 M
|
![]() USA
|
![]() C4 Therapeutics
CCCC
|
$84.48 M |
0.000 M
|
![]() USA
|
![]() Nurix Therapeutics
NRIX
|
$0.75 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Monte Rosa Therapeutics
GLUE
|
$0.27 B |
0.000 M
|
![]() USA
|
![]() Foghorn Therapeutics
FHTX
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.75 B |
0.000 M
|
![]() USA
|
![]() Schrödinger
SDGR
|
$1.87 B |
0.235 B
|
![]() USA
|
![]() IDEAYA Biosciences
IDYA
|
$1.49 B |
0.000 M
|
![]() USA
|
![]() Kronos Bio
KRON
|
$52.92 M |
0.000 M
|
![]() USA
|
![]() Olema Pharmaceuticals
OLMA
|
$0.29 B |
-0.000 M
|
![]() USA
|
![]() Zentalis Pharmaceuticals
ZNTL
|
$91.20 M |
0.000 M
|
![]() USA
|
Market Cap | = | KYMR Stock Price | * | KYMR Shares Outstanding |
= | $25.46 | * | 64.94 M | |
= | $1.65 B |